Stephanie Gaillard, MD PhD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Volastra
    Date added:
    08/21/2024
    Date updated:
    08/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Astra-Zeneca
    Topic:
    Advisory Board
    Date added:
    08/21/2024
    Date updated:
    08/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Volastra
    Date added:
    08/21/2024
    Date updated:
    08/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Compugen
    Date added:
    08/21/2024
    Date updated:
    08/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Beigene
    Date added:
    08/21/2024
    Date updated:
    08/21/2024

Pages

Return to Sept. 27-28, 2024 - Symposium for Evolving Therapies and Drug Development in Oncology